Abbott Laboratories

NYSE: ABT
$105.27
-$0.63 (-0.6%)
Closing price April 18, 2024
Abbott Laboratories is a global healthcare company with a broad portfolio of products across various segments, including pharmaceuticals, diagnostics, nutritional products, and medical devices. Founded in 1888 and headquartered in North Chicago, Illinois, Abbott is known for its innovative solutions in managing health conditions such as diabetes, cardiovascular diseases, and chronic pain. It also offers a range of diagnostics equipment and tests for infectious diseases, including HIV and influenza, as well as nutritional products for both pediatric and adult patients. Abbott's commitment to improving lives is evident through its diverse offerings aimed at enhancing health and well-being worldwide.
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Antero Midstream, C3.ai, Equitrans Midstream, Hewlett Packard Enterprise, iQIYI, Johnson & Johnson, Opendoor Technologies,...
Wednesday afternoon's top analyst upgrades and downgrades included Abbott Laboratories, Camping World, Chevron, Endo International, Marathon Oil, Meta Platforms and Opendoor Technologies.
Given Warren Buffet's proclivity for only owning stock of companies that he understands inside and out, these 10 top health care picks with big, dependable dividends make sense now for growth and...
These five stocks are on the Dividend Aristocrats list, are in defensive sectors and look poised to do well the rest of 2022. They are Buy rated at top Wall Street firms as well. With interest rates...
Friday's top analyst upgrades and downgrades included Abbott Laboratories, ArcelorMittal, AT&T, Chewy, Clean Energy Fuels, Fisker, Freeport-McMoRan, Intel, Las Vegas Sands, Lennar, Marathon Digital,...
Here is a preview of four earnings reports due out before markets open on Wednesday.
Thursday's top analyst upgrades and downgrades included AT&T, Abbott Laboratories, Advanced Micro Devices, Affirm, Canopy Growth, Cleanspark, Eli Lilly, ESS Tech, Global Payments and Luminar...
Friday afternoon's top analyst upgrades and downgrades included Bank of America, Chewy, Costco, Lululemon, Oracle, Peloton, Roku and more.
Broadcom, Pfizer and these other top companies are expected to lift the dividends they pay to shareholders, and their stocks are rated Buy across Wall Street, making them excellent total return...
Now is the time to reduce risk and more to safer ideas. Top-quality health care stocks may be the way to go for the rest of 2021 and in 2022, and these five Dividend Aristocrats make good sense now...
Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Alphabet, Cloudflare, DraftKings, FuboTV, Microsoft and UPS.
Thursday's top analyst upgrades and downgrades included AT&T, Abbott Laboratories, Avis Budget, Bed Bath & Beyond, Beyond Meat, Caterpillar, UPS, Walmart and Wynn Resorts.
Tuesday's top analyst upgrades and downgrades included Abbott Laboratories, Adobe, Canopy Growth, Coinbase, Dollar General, Domino's Pizza, Medtronic, Palo Alto Networks and Target.
Earnings season hits its stride next week and here are previews of four companies reporting March quarter results on Monday and Tuesday.
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Anheuser-Busch Inbev, Coinbase, CrowdStrike, General Motors, Hershey, Medtronic and UPS.